Search alternatives:
forests current » concepts current, contents current, currents current
costs current » assets current, robots current, its current
Cover Image
Read Now

1
by Ho, Chuong, Spry, Carolyn
Published 2017
Canadian Agency for Drugs and Technologies in Health
“... remission induction and remission maintenance. Currently, rituximab, a monoclonal antibody, is one...”
Cover Image
Read Now

2
by Ho, Chuong, Spry, Carolyn
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: “...Cost-Benefit Analysis...”
Cover Image
Read Now

3
by Ho, Chuong, Adcock, Lorna
Published 2018
CADTH
“... remission induction and remission maintenance. Currently, rituximab, a monoclonal antibody, is one...”
Cover Image
Read Now

5
by Ho, Chuong, Visintini, Sarah
Published 2018
Canadian Agency for Drugs and Technologies in Health
“...This Rapid Response report aims to review the clinical and cost-effectiveness of the riskbased...”
Cover Image
Read Now

6
by Ho, Chuong, Visintini, Sarah
Published 2018
Canadian Agency for Drugs and Technologies in Health
“...This Rapid Response report aims to review the clinical and cost-effectiveness of the riskbased...”